Authors:
SASS DA
RUCINSKI B
BRYER HP
MANN GN
YUAN Z
MA Y
JEE WSS
EPSTEIN S
Citation: Da. Sass et al., COMBINED FLURBIPROFEN AND CYCLOSPORINE-A DOES NOT ATTENUATE BONE LOSSAND EXAGGERATES RENAL IMPAIRMENT, Bone, 19(4), 1996, pp. 381-386
Authors:
MANN GN
SASS DA
CHEN HK
BUCHINSKY FJ
BRYER HP
MA YF
JEE WSS
RUCINSKI B
EPSTEIN S
Citation: Gn. Mann et al., SHORT-TERM SYSTEMIC INSULIN-LIKE GROWTH-FACTOR-I IS UNABLE TO PREVENTCYCLOSPORINE-A-INDUCED OSTEOPENIA IN THE RAT, Calcified tissue international, 59(1), 1996, pp. 38-44
Authors:
BUCHINSKY FJ
MA YF
MANN GN
RUCINSKI B
BRYER HP
ROMERO DF
JEE WSS
EPSTEIN S
Citation: Fj. Buchinsky et al., T-LYMPHOCYTES PLAY A CRITICAL ROLE IN THE DEVELOPMENT OF CYCLOSPORINE-A-INDUCED OSTEOPENIA, Endocrinology, 137(6), 1996, pp. 2278-2285
Authors:
BUCHINSKY FJ
MA YF
MANN GN
RUCINSKI B
BRYER HP
PAYNTON BV
JEE WSS
HENDY GN
EPSTEIN S
Citation: Fj. Buchinsky et al., BONE-MINERAL METABOLISM IN T-LYMPHOCYTE-DEFICIENT AND T-LYMPHOCYTE-REPLETE STRAINS OF RAT, Journal of bone and mineral research, 10(10), 1995, pp. 1556-1565
Authors:
BRYER HP
ISSEROW JA
ARMSTRONG EC
MANN GN
RUCINSKI B
BUCHINSKY FJ
ROMERO DF
EPSTEIN S
Citation: Hp. Bryer et al., AZATHIOPRINE ALONE IS BONE-SPARING AND DOES NOT ALTER CYCLOSPORINE-A-INDUCED OSTEOPENIA IN THE RAT, Journal of bone and mineral research, 10(1), 1995, pp. 132-138
Authors:
ISSEROW JA
SASS DA
BRYER HP
MANN GN
BUCHINSKY FJ
YUAN Z
MA YF
JEE WSS
EPSTEIN S
Citation: Ja. Isserow et al., ANTI-PROSTAGLANDIN THERAPY DOES NOT REVERSE CYCLOSPORINE-INDUCED OSTEOPENIA, Journal of bone and mineral research, 10, 1995, pp. 249-249
Citation: B. Rucinski et al., A NEW RAPID AND REPRODUCIBLE HOMOLOGOUS IMMUNORADIOMETRIC ASSAY FOR AMINO-TERMINAL PARATHYROID-HORMONE IN THE RAT, Calcified tissue international, 56(1), 1995, pp. 83-87
Authors:
ISSEROW JA
RUCINSKI B
ROMERO DF
MANN GN
LIU CC
EPSTEIN S
Citation: Ja. Isserow et al., THE EFFECT OF MEDROXYPROGESTERONE ACETATE ON BONE METABOLISM IN THE OOPHORECTOMIZED, TAMOXIFEN-TREATED RAT, Endocrinology, 136(2), 1995, pp. 713-719
Authors:
MANN GN
BUCHINSKY FJ
BRYER HP
ISSEROW JA
LI M
KE HZ
MA YF
JEE WSS
EPSTEIN S
Citation: Gn. Mann et al., INTERFERON-GAMMA CAUSES LOSS OF TRABECULAR BONE IN-VIVO AND DOES NOT INFLUENCE CYCLOSPORINE-A-INDUCED BONE-DISEASE SHORT-TERM, Journal of the American Society of Nephrology, 5(3), 1994, pp. 853-853
Authors:
CVETKOVIC M
MANN GN
ROMERO DF
LIANG XG
MA YF
JEE WSS
EPSTEIN S
Citation: M. Cvetkovic et al., THE DELETERIOUS EFFECTS OF LONG-TERM CYCLOSPORINE-A, CYCLOSPORINE-G, AND FK506 ON BONE-MINERAL METABOLISM IN-VIVO, Transplantation, 57(8), 1994, pp. 1231-1237
Authors:
MANN GN
JACOBS TW
BUCHINSKY FJ
ARMSTRONG EC
LI M
KE HZ
MA YF
JEE WSS
EPSTEIN S
Citation: Gn. Mann et al., INTERFERON-GAMMA CAUSES LOSS OF BONE VOLUME IN-VIVO AND FAILS TO AMELIORATE CYCLOSPORINE-A-INDUCED OSTEOPENIA, Endocrinology, 135(3), 1994, pp. 1077-1083
Authors:
BUCHINSKY FJ
MA YF
MANN GN
ISSEROW JA
RUCINSKI B
CVETKOVIC M
ROMERO DF
BRYER HP
ARMSTRONG EC
JEE WSS
EPSTEIN S
Citation: Fj. Buchinsky et al., THE ROLE OF T-LYMPHOCYTES IN CYCLOSPORINE-A (CSA) INDUCED OSTEOPOROSIS, Clinical research, 42(2), 1994, pp. 10000276-10000276
Citation: B. Rucinski et al., A NEW REPRODUCIBLE AND ACCURATE RADIOIMMUNOASSAY FOR PARATHYROID-HORMONE IN RAT SERUM, Journal of bone and mineral research, 8, 1993, pp. 190000194-190000194
Authors:
CVETKOVIC M
ROMERO D
MANN GN
LIANG XZ
MA WF
JEE W
EPSTEIN S
Citation: M. Cvetkovic et al., DOES THE IMMUNOSUPPRESSANT FK-506 POSE A LESSER RISK TO BONE THAN CYCLOSPORINE-A OR CYCLOSPORINE-G, Journal of bone and mineral research, 8, 1993, pp. 190000340-190000340
Citation: Gn. Mann et al., EVIDENCE FOR THE ROLE OF A BASOLATERAL NA K/2CL-COTRANSPORTER IN CELL-VOLUME REGULATION IN INDIVIDUAL CRYPTS OF THE RABBIT COLON/, Gastroenterology, 104(4), 1993, pp. 263-263
Citation: Gn. Mann et al., EFFECT OF METABOLIC SUBSTRATES ON MAINTENANCE OF CELLULAR ATP IN INDIVIDUAL CRYPTS OF THE RABBIT COLON, Gastroenterology, 104(4), 1993, pp. 634-634